2020
Adult H3K27M-mutant diffuse midline glioma with gliomatosis cerebri growth pattern: Case report and review of the literature
Yekula A, Gupta M, Coley N, U HS. Adult H3K27M-mutant diffuse midline glioma with gliomatosis cerebri growth pattern: Case report and review of the literature. International Journal Of Surgery Case Reports 2020, 68: 124-128. PMID: 32145563, PMCID: PMC7058855, DOI: 10.1016/j.ijscr.2020.02.046.Peer-Reviewed Original ResearchDiffuse midline gliomaH3K27M-mutant diffuse midline gliomaGliomatosis cerebri growth patternMidline gliomaGrade IV lesionsH3K27M mutationEarly biopsyClinicopathologic characteristicsDisease courseInfiltrative neoplasmPediatric patientsLeptomeningeal involvementPoor prognosisVentricular shuntingPatient counselingSuboccipital craniotomyVisual deteriorationCase reportCapsular lesionsPosterior fossaHigh indexChoroid plexusInfectious pathologyAccurate diagnosisGliomas
2003
Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma
Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E. Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma. Cancer 2003, 97: 2972-2977. PMID: 12784331, DOI: 10.1002/cncr.11436.Peer-Reviewed Original ResearchConceptsPercent of patientsMetastatic breast carcinomaTrastuzumab-based therapyCentral nervous system metastasesCentral nervous system diseaseNervous system metastasesCNS diseaseNervous system diseasesBreast carcinomaBrain metastasesCNS metastasesLeptomeningeal involvementSystem diseasesDisease sitesMore brain metastasesParenchymal brain metastasesProgressive CNS diseaseFirst-line therapyTime of diagnosisMedian survival periodBlood-brain barrierNew treatment strategiesStable diseaseMetastatic diseasePharmacy records
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply